Gsa Capital Partners LLP Matinas Bio Pharma Holdings, Inc. Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$0.92 - $1.22 $684,502 - $907,709
-744,024 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$0.67 - $1.51 $630,351 - $1.42 Million
-940,823 Reduced 55.84%
744,024 $967,000
Q2 2021

Aug 05, 2021
BUY
$0.75 - $1.1 $1.26 Million - $1.85 Million
1,684,847 New
1,684,847 $1.31 Million
Q3 2020

Nov 06, 2020
SELL
$0.67 - $0.96 $12,870 - $18,440
-19,209 Closed
0 $0
Q2 2020

Aug 11, 2020
BUY
$0.52 - $0.92 $9,988 - $17,672
19,209 New
19,209 $15,000

Others Institutions Holding MTNB

# of Institutions
6
Shares Held
3.52M
Call Options Held
0
Put Options Held
0
View Full List

About Matinas BioPharma Holdings, Inc.

MTNB Quotes by TradingView
  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $130M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email